نتایج جستجو برای: oral iron chelators

تعداد نتایج: 392992  

Journal: :Cancer research 1989
J Blatt S R Taylor G J Kontoghiorghes

The iron chelator, deferoxamine, has demonstrated cytotoxicity against neuroblastoma cells. In this study we examined the in vitro antineuroblastoma activity of several potentially less expensive oral chelating agents. On a mole for mole basis, 1-hydroxypyridine-2-thionine (omadine) had 100 times the cytotoxicity of deferoxamine. 1,2-Dimethyl-3-hydroxypyrid-4-one also caused demonstrable cell d...

Journal: :Blood 2012
A Victor Hoffbrand Ali Taher Maria Domenica Cappellini

Patients with β-thalassemia major (TM) and other refractory anemias requiring regular blood transfusions accumulate iron that damages the liver, endocrine system, and most importantly the heart. The prognosis in TM has improved remarkably over the past 10 years. This improvement has resulted from the development of magnetic resonance imaging (MRI) techniques, especially T2*, to accurately measu...

Journal: :The Journal of biological chemistry 1991
E R Stadtman B S Berlett

The oxidation of amino acids by Fenton reagent (H2O2 + Fe(II] leads mainly to the formation of NH+4, alpha-ketoacids, CO2, oximes, and aldehydes or carboxylic acids containing one less carbon atom. Oxidation is almost completely dependent on the presence of bicarbonate ion and is stimulated by iron chelators at levels which are substoichiometric with respect to the iron concentration but is inh...

2013
Katsuyasu Saigo Mari Kono Yuri Takagi Mariko Takenokuchi Yasushi Hiramatsu Hiroshi Tada Terutoshi Hishita Masahito Misawa Shion Imoto Shinsaku Imashuku

BACKGROUND Iron chelation therapy is useful against the over-accumulation of iron and is expected to reduce oxidative stress resulting from the Fenton reaction and Haber-Weiss reaction. We monitored oxidative status and serum ferritin levels after in vivo administration of deferasirox (DFS) and studied the in vitro effects of iron chelators on neutrophil function. METHODS Nine patients suffer...

Journal: :Acta haematologica 2013
Khaled M Musallam Michael Angastiniotis Androulla Eleftheriou John B Porter

Efforts to optimize the management of patients with β-thalassemia major (TM) continue to expand. Evidence from biomedical research evaluating safe and careful processing measures of blood products, the efficacy and safety of oral iron chelators, and noninvasive techniques for the assessment of iron overload are translated into better patient outcomes. The construction of TM management guideline...

Journal: :Journal of Advances in Medical and Pharmaceutical Sciences 2017

Journal: :Organic & biomolecular chemistry 2014
Etienne Baco Françoise Hoegy Isabelle J Schalk Gaëtan L A Mislin

Catechols are components of many metal-chelating compounds, including siderophores that are naturally occurring iron(III) chelators excreted by microorganisms. Catechol derivatives are poorly soluble in organic media and the synthesis of catechol-containing molecules requires the use of protected catechol precursors with improved organic solubility. We therefore developed 2,2-diphenyl-benzo[1,3...

2015
Galina Ling Vered Pinsk Inbal Golan-Tripto Eduard Ling

Congenital dyserythropoietic anemias (CDA) represent a heterogeneous group of disorders characterized by morphological abnormalities of erythroid precursor cells and various degrees of hemolysis. Iron overload is a result of continuous hemolysis and recurrent transfusions. It is treated with iron chelators, including deferasirox. We present here a case of acute liver failure in a 12 years old g...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید